摘要
目的研究血常规检验对炎症性肠病的诊断价值。方法选取98例病理学诊断为炎症性肠病的患者作为研究组,另选取98例健康体检者作为参照组。两组研究对象均进行血常规检验。分析比较两组研究对象平均红细胞比容、C反应蛋白、平均红细胞血红蛋白浓度、血红蛋白浓度及血小板计数。结果研究组平均红细胞比容(84.02±10.03)fl、平均红细胞血红蛋白浓度(317.55±17.03)g/L、血红蛋白浓度(120.25±18.44)g/L均低于参照组的(89.29±15.26)fl、(329.56±17.26)g/L、(128.39±14.56)g/L,C反应蛋白(19.77±7.26)mg/L、血小板计数(187.69±23.45)×10^9/L均高于参照组的(9.22±2.15)mg/L、(157.69±16.20)×10^9/L,差异具有统计学意义(P<0.05)。结论通过血常规参数可明确诊断炎症性肠病,可及早诊断,为炎症性肠病患者的长期间歇性治疗提供病情的参考信息,积极进行治疗,提高患者生活质量。
Objective To study the value of routine blood test in the diagnosis of inflammatory bowel disease.Methods There was 98 patients with inflammatory bowel disease diagnosed by pathology selected as the research group,and 98 healthy subjects as the control group.Blood routine test was performed in both groups.The mean hematocrit,C-reactive protein,mean corpuscular hemoglobin concentration,hemoglobin concentration and platelet count of the two groups were analyzed and compared.Results The mean hematocrit(84.02±10.03)fl,mean corpuscular hemoglobin concentration(317.55±17.03)g/L,hemoglobin concentration(120.25±18.44)g/L of the research group were lower than(89.29±15.26)fl,(329.56±17.26)g/L,(128.39±14.56)g/L of the control group,and C-reactive protein(19.77±7.26)mg/L and platelet count(187.69±23.45)×10^9/L were higher than(9.22±2.15)mg/L and(157.69±16.20)×10^9/L of the control group,and the difference was statistically significant(P<0.05).Conclusion The blood routine parameters can clearly diagnose inflammatory bowel disease,provide reference information for the long-term intermittent treatment of patients with inflammatory bowel disease,and actively carry out treatment,thereby improving the quality of life of patients.
作者
刘晓舟
LIU Xiao-zhou(Department of Clinical Laboratory,Shenyang Weikang Hospital,Shenyang 110021,China)
出处
《中国实用医药》
2021年第3期28-30,共3页
China Practical Medicine